Ming Shi

8.7k total citations · 2 hit papers
91 papers, 4.2k citations indexed

About

Ming Shi is a scholar working on Immunology, Epidemiology and Hepatology. According to data from OpenAlex, Ming Shi has authored 91 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Immunology, 38 papers in Epidemiology and 23 papers in Hepatology. Recurrent topics in Ming Shi's work include Hepatitis B Virus Studies (28 papers), Immune Cell Function and Interaction (28 papers) and HIV Research and Treatment (21 papers). Ming Shi is often cited by papers focused on Hepatitis B Virus Studies (28 papers), Immune Cell Function and Interaction (28 papers) and HIV Research and Treatment (21 papers). Ming Shi collaborates with scholars based in China, United States and Japan. Ming Shi's co-authors include Fu‐Sheng Wang, Junliang Fu, Zheng Zhang, Ruonan Xu, Zhengsheng Zou, Hui Zhang, Chun‐Bao Zhou, Ji‐Yuan Zhang, Lei Jin and Lei Jin and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ming Shi

84 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients

2007 725 citations Junliang Fu, Zhenwen Liu et al. Gastroenterology profile →
PGLYRP2 drives hepatocyte-intrinsic innate immunity by trapping and clearing hepatitis B virus

2025 17 citations Ming Shi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ming Shi China	27	1.8k	1.5k	1.3k	791	752	91	4.2k
Junliang Fu China	29	2.2k 1.2×	1.8k 1.2×	1.6k 1.3×	915 1.2×	638 0.8×	90	4.7k
Ruonan Xu China	25	768 0.4×	949 0.6×	923 0.7×	205 0.3×	682 0.9×	80	2.7k
Minoru Nakamura Japan	36	1.2k 0.7×	1.5k 1.0×	1.5k 1.1×	427 0.5×	780 1.0×	130	3.9k
Bertram Bengsch Germany	30	3.3k 1.8×	1.1k 0.7×	872 0.7×	1.5k 1.9×	440 0.6×	73	4.9k
Massimo Fiorilli Italy	28	1.1k 0.6×	584 0.4×	539 0.4×	284 0.4×	171 0.2×	118	2.5k
Alberto Sánchez‐Fueyo United Kingdom	42	3.0k 1.6×	1.4k 1.0×	1.9k 1.5×	815 1.0×	2.1k 2.7×	118	6.4k
Masahiro Imamura Japan	34	1.3k 0.7×	642 0.4×	384 0.3×	931 1.2×	353 0.5×	218	3.9k
Natacha Patey France	21	1.5k 0.8×	918 0.6×	202 0.2×	333 0.4×	713 0.9×	38	3.2k
Åke Öst Sweden	35	977 0.5×	764 0.5×	114 0.1×	868 1.1×	592 0.8×	112	4.4k
Dave Sprengers Netherlands	36	1.3k 0.7×	954 0.6×	1.1k 0.8×	1.3k 1.7×	377 0.5×	101	3.5k

Countries citing papers authored by Ming Shi

Since Specialization

Citations

This map shows the geographic impact of Ming Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Shi more than expected).

Fields of papers citing papers by Ming Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Shi. The network helps show where Ming Shi may publish in the future.

Co-authorship network of co-authors of Ming Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Shi. A scholar is included among the top collaborators of Ming Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Shi. Ming Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Siyu, Tao Yang, Tiantian Li, et al.. (2025). Safety and efficacy of human umbilical cord-derived mesenchymal stem cells in COVID-19 patients: A real-world observation. Chinese Medical Journal. 138(22). 2984–2992. 1 indexed citations

Hu, Liyun, X. B. Yang, Xuan Xia, et al.. (2025). Fabrication of FeAl-LDH onto sponge for efficient chromium(VI) immobilization and reduction in soil remediation. Environmental Engineering Research. 31(2). 250330–0.

Li, Mengyao, Tao Yang, Yunbo Xie, et al.. (2024). Human umbilical cord mesenchymal stem cell transplantation for the treatment of acute-on-chronic liver failure: protocol for a multicentre random double-blind placebo-controlled trial. BMJ Open. 14(6). e084237–e084237.

Fu, Yulong, Wei Hu, Jing Li, et al.. (2023). Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis B. Hepatology International. 17(5). 1125–1138. 3 indexed citations

Zhou, Ming‐Ju, Chao Zhang, Haiyan Wang, et al.. (2023). Cured HCV patients with suboptimal hepatitis B vaccine response exhibit high self-reactive immune signatures. Hepatology Communications. 7(7). 1 indexed citations

Wang, Zerui, Ziying Zhang, Mengqi Yuan, et al.. (2023). Human umbilical cord-derived mesenchymal stem cells for the treatment of decompensated cirrhosis (MSC-DLC-1): a dose-escalation, phase I trial protocol. BMJ Open. 13(12). e078362–e078362. 3 indexed citations

Liu, Jiaye, Yan Zhao, Yasong Wu, et al.. (2021). Epidemiological trends of severely immunosuppressed people living with HIV at time of starting antiretroviral treatment in China during 2005–2018. Journal of Infection. 84(3). 400–409. 6 indexed citations

Xu, Ruonan, Jiyuan Zhang, Bo Tu, et al.. (2021). HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patients. Signal Transduction and Targeted Therapy. 6(1). 174–174. 3 indexed citations

Liu, Jiaye, Lifeng Wang, Yan Zhao, et al.. (2020). Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study. Emerging Microbes & Infections. 9(1). 2550–2561. 24 indexed citations

10.

Jiao, Yan‐Mei, Chao Zhang, Ji‐Yuan Zhang, et al.. (2020). Transforming growth factor‐β promotes the function of HIV‐specific CXCR5⁺CD8 T cells. Microbiology and Immunology. 64(6). 458–468. 3 indexed citations

11.

Jiao, Yan‐Mei, Chao Zhang, Jin‐Wen Song, et al.. (2020). HIV Reservoir Decay and CD4 Recovery Associated With High CD8 Counts in Immune Restored Patients on Long-Term ART. Frontiers in Immunology. 11. 1541–1541. 15 indexed citations

12.

Sun, Yanling, et al.. (2019). Circulating CXCR3-CCR6-CXCR5+CD4+ T cells are associated with acute allograft rejection in liver transplantation. Immunology Letters. 213. 55–61. 7 indexed citations

13.

Chang, Binxia, Ang Huang, Miaomiao Gao, et al.. (2018). Plasma levels of soluble ST2, but not IL‐33, correlate with the severity of alcoholic liver disease. Journal of Cellular and Molecular Medicine. 23(2). 887–897. 18 indexed citations

14.

Min, Haiyan, Sanbin Wang, Yuqin Song, et al.. (2018). Remission of HIV-related naïve and high-risk Burkitt’s lymphoma treated by autologous stem cell transplantation plus cART. Stem Cell Research & Therapy. 9(1). 353–353. 2 indexed citations

15.

Zhang, Zheng, Hu Lin, Ming Shi, et al.. (2012). Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. Journal of Gastroenterology and Hepatology. 27(s2). 112–120. 273 indexed citations

16.

Shi, Ming, Junliang Fu, Shi Feng, et al.. (2009). Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection. Clinical Immunology. 132(1). 43–54. 20 indexed citations

17.

Shi, Ming, et al.. (2008). Comparison of real-time polymerase chain reaction with the COBAS Amplicor test for quantitation of hepatitis B virus DNA in serum samples. World Journal of Gastroenterology. 14(3). 479–479. 9 indexed citations

18.

Fu, Junliang, Zhenwen Liu, Ming Shi, et al.. (2007). Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients. Gastroenterology. 132(7). 2328–2339. 725 indexed citations breakdown →

19.

Xu, Dongping, Junliang Fu, Lei Jin, et al.. (2006). Circulating and Liver Resident CD4+CD25+ Regulatory T Cells Actively Influence the Antiviral Immune Response and Disease Progression in Patients with Hepatitis B. The Journal of Immunology. 177(1). 739–747. 373 indexed citations

20.

Zhang, Zheng, Dongping Xu, Yonggang Li, et al.. (2005). Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome. Clinical Immunology. 116(3). 225–235. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact